ReShape Lifesciences Other Long-Term Assets 2015-2024 | RSLS

ReShape Lifesciences other long-term assets from 2015 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.

ReShape Lifesciences Other Long-Term Assets 2015-2024 | RSLS

ReShape Lifesciences other long-term assets from 2015 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$197.4B
Intuitive Surgical (ISRG)$196.1B
Alcon (ALC)$42.2B
Edwards Lifesciences (EW)$41.5B
IQVIA Holdings (IQV)$35.9B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$29.1B
Waters (WAT)$21.9B
STERIS (STE)$21.3B
SONOVA HOLDING (SONVY)$20.5B
Hologic (HOLX)$18.3B
Fresenius Medical Care AG KGaA (FMS)$12.9B
Sysmex ADR (SSMXY)$12.8B
Globus Medical (GMED)$11.6B
Penumbra (PEN)$9.2B
Masimo (MASI)$9.1B
Teleflex (TFX)$8.9B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.6B
Veracyte (VCYT)$3B
Inari Medical (NARI)$2.9B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.7B
Nihon Kohden (NHNKY)$2.4B
Elekta AB (EKTAY)$2.1B
Tandem Diabetes Care (TNDM)$2B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B